Literature DB >> 21536981

Estrogen-independent activation of estrogen receptors.

Matthias Barton, Matthias R Meyer, Eric R Prossnitz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21536981      PMCID: PMC3131133          DOI: 10.1161/HYPERTENSIONAHA.111.173427

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  16 in total

1.  The GPER1 agonist G-1 attenuates endothelial cell proliferation by inhibiting DNA synthesis and accumulating cells in the S and G2 phases of the cell cycle.

Authors:  Anders Holm; Bo Baldetorp; Björn Olde; L M Fredrik Leeb-Lundberg; Bengt-Olof Nilsson
Journal:  J Vasc Res       Date:  2011-01-27       Impact factor: 1.934

Review 2.  Protective effects of estrogen and selective estrogen receptor modulators in the brain.

Authors:  Krishnan M Dhandapani; Darrell W Brann
Journal:  Biol Reprod       Date:  2002-11       Impact factor: 4.285

3.  Estrogen or the AT1 antagonist olmesartan reverses the development of profound hypertension in the congenic mRen2. Lewis rat.

Authors:  Mark C Chappell; Patricia E Gallagher; David B Averill; Carlos M Ferrario; K Bridget Brosnihan
Journal:  Hypertension       Date:  2003-07-21       Impact factor: 10.190

Review 4.  Postmenopausal hypertension: mechanisms and therapy.

Authors:  Matthias Barton; Matthias R Meyer
Journal:  Hypertension       Date:  2009-05-26       Impact factor: 10.190

5.  Inhibitory effects of AT1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress.

Authors:  Masahiro Tsuda; Masaru Iwai; Jian-Mei Li; Huan-Sheng Li; Li-Juan Min; Ayumi Ide; Midori Okumura; Jun Suzuki; Masaki Mogi; Hiromichi Suzuki; Masatsugu Horiuchi
Journal:  Hypertension       Date:  2005-02-21       Impact factor: 10.190

6.  Activation of estrogen receptor-α and of angiotensin-converting enzyme 2 suppresses ischemic brain damage in oophorectomized rats.

Authors:  Kenji Shimada; Keiko T Kitazato; Tomoya Kinouchi; Kenji Yagi; Yoshiteru Tada; Junichiro Satomi; Teruyoshi Kageji; Shinji Nagahiro
Journal:  Hypertension       Date:  2011-05-02       Impact factor: 10.190

7.  Angiotensin type 1 receptor blocker reduces intimal neovascularization and plaque growth in apolipoprotein E-deficient mice.

Authors:  Xian Wu Cheng; Haizhen Song; Takeshi Sasaki; Lina Hu; Aiko Inoue; Yasuko K Bando; Guo-Ping Shi; Masafumi Kuzuya; Kenji Okumura; Toyoaki Murohara
Journal:  Hypertension       Date:  2011-04-04       Impact factor: 10.190

8.  Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes.

Authors:  Hermann Haller; Sadayoshi Ito; Joseph L Izzo; Andrzej Januszewicz; Shigehiro Katayama; Jan Menne; Albert Mimran; Ton J Rabelink; Eberhard Ritz; Luis M Ruilope; Lars C Rump; Giancarlo Viberti
Journal:  N Engl J Med       Date:  2011-03-10       Impact factor: 91.245

9.  Estrogen receptor-mediated vascular responsiveness to nebivolol: a novel endothelium-related mechanism of therapeutic vasorelaxation.

Authors:  Hermes J Garbán; Georgette M Buga; Louis J Ignarro
Journal:  J Cardiovasc Pharmacol       Date:  2004-05       Impact factor: 3.105

10.  17beta-Estradiol modulates local cardiac renin-angiotensin system to prevent cardiac remodeling in the DOCA-salt model of hypertension in rats.

Authors:  V Shenoy; J L Grobe; Y Qi; A J Ferreira; R A Fraga-Silva; G Collamat; E Bruce; M J Katovich
Journal:  Peptides       Date:  2009-09-09       Impact factor: 3.750

View more
  5 in total

Review 1.  Twenty years of the G protein-coupled estrogen receptor GPER: Historical and personal perspectives.

Authors:  Matthias Barton; Edward J Filardo; Stephen J Lolait; Peter Thomas; Marcello Maggiolini; Eric R Prossnitz
Journal:  J Steroid Biochem Mol Biol       Date:  2017-03-25       Impact factor: 4.292

Review 2.  Nox1 downregulators: A new class of therapeutics.

Authors:  Matthias Barton; Matthias R Meyer; Eric R Prossnitz
Journal:  Steroids       Date:  2019-09-10       Impact factor: 2.668

3.  Estrogen and glucocorticoid receptor agonists and antagonists in oocytes modulate the pattern of expression of genes that encode nuclear receptor proteins in very early stage rainbow trout (Oncorhynchus mykiss) embryos.

Authors:  Jacqueline Ferris; Mao Li; John F Leatherland; W Allan King
Journal:  Fish Physiol Biochem       Date:  2014-12-19       Impact factor: 2.794

4.  Membrane estrogen receptor alpha is an important modulator of bone marrow C-Kit+ cells mediated cardiac repair after myocardial infarction.

Authors:  Feng Su; Wentian Zhang; Jianfang Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

5.  GPER/GPR30 and Regulation of Vascular Tone and Blood Pressure.

Authors:  Matthias R Meyer; Eric R Prossnitz; Matthias Barton
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2011
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.